Are you a Patentee?
Pre-July 1, 2022 PMPRB Framework
Pre-July 1, 2022 PMPRB Framework
The information on this page reflects the PMPRB Compendium of Policies, Guidelines and Procedures which were in place until June 30, 2022. The Form 2 filing templates below are to be used to report data up to and including December 31, 2021.
The reporting requirements in place as of July 1, 2022, can be found by clicking the “Post-July 1, 2022 PMPRB Framework” button above.
The statutory reporting requirements are described in the Patented Medicines Regulations.
Filing
- Online Filing Tool
- Filing Requirements and Deadlines
- Form 2: Information on the Identity of Prices of the Medicine
- Form 2: Blocks 1, 2, 3, and Signature (XLS 45 KB)
- Form 2: Block 4: Sales of the medicine by the reporting patentee in final dosage form in Canada (XLS 121 KB)
- Form 2: Block 5: Publicly available ex-factory prices for Canada and other countries (XLS 119 KB)
- Form 2 Block 4 and Block 5 Online Filing Help Tool
- Form 3: Revenues and Research and Development Expenditures Provided Pursuant to subsection 88(1) of the Patent Act (XLS 39 KB)
- CPI-adjustment factors
- Exchange rates
- Potential Sources for Foreign Prices PMPRB7
Scientific Review
Other
Post-July 1, 2022 PMPRB Framework
Post-July 1, 2022 PMPRB Framework
The information on this page reflects the PMPRB framework in place as of July 1, 2022.
The information reflecting the PMPRB Compendium of Policies, Guidelines and Procedures can be found by clicking the “Pre-July 1, 2022 PMPRB Framework” button above. Form 2 filing templates pertaining to the reporting of data prior to January 1, 2022, can also be found at this link.
The statutory reporting requirements are described in the Patented Medicines Regulations.
Filing
- Online Filing Tool
- Filing Requirements and Deadlines
- Form 2: Information on the Identity of Prices of the Medicine
- CPI-adjustment factors
- Exchange rates
- Potential Sources for Foreign Prices: PMPRB11
Scientific Review
Page details
- Date modified: